← All stocks

DiaMedica Therapeutics Inc.

DMAC Net buying

CIK 0001401040 #3414 in the set updated 18 Sep 2026

Bought (12 mo)

$7.63M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$7.63M

+$7.63M against sales at will

By person

9 insiders · 8 transactions

1.7×

Rick Pauls holds only 1.7 times base salary in stock. $1.10M of shares against $645.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Rick Pauls last reported holding, valued at $8.57, the price Common Shares was last bought or sold at on the open market here, on 25 Nov 2025.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

STAHLBERG JAN

10% owner

$7.63M (7)

—

+$7.63M

8,825,742

16.37%

$75.68M

+69.0%

Von Koch Thomas

10% owner

—

8,383,577

15.55%

$71.89M

+51.7%

JACINTO RICHARD II

10% owner

—

4,958,823

9.20%

$42.52M

+8.8%

Giuffre Randall Michael

Director

—

398,587

0.7391%

$3.42M

+9.3%

Pilnik Richard D.

Director

—

312,995

0.5804%

$2.68M

+12.3%

Pauls Dietrich John

President & CEO

—

128,791

0.2388%

$1.10M

+87.8%

Parsons James T.

Director

—

97,949

0.1816%

$839.90K

+63.4%

Semba Charles Pauling

Director

—

47,963

0.0889%

$411.28K

+22.0%

Kuntz Richard

Director

—

24,210

0.0449%

$207.60K

+69.5%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 16

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 91,825

History held since 11 Dec 2018